Welcome to the international HTA database

Showing [24069 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single-use medical devices: clinical, economic, and health services impact
2008	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single-use medical devices: national survey of Canadian acute-care hospitals
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of surgical drills
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of surgical drills
2008	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of tourniquet cuffs
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of ultrasonic scalpels
1996	Health Council of the Netherlands Gezondheidsraad (GR)	Requirements for expertise in radiation applications in medicine
2008	Health Intervention and Technology Assessment Program (HITAP)	Research for development of an optimal policy strategy for prevention and control of Cervical Cancer in Thailand
2001	Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS)	Research on human beings. Report about the hearing on September 24, 2001 in Berne
2002	Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS)	Research on human embryonic stem cells. Report about citizen opinions
1998	TNO	Research questions in the home care technology program
2015	NIHR Health Services and Delivery Research programme	Research utilisation and knowledge mobilisation in the commissioning and joint planning of public health interventions to reduce alcohol-related harms: a qualitative case design using a cocreation approach
2015	NIHR Health Services and Delivery Research programme	ReseArch with Patient and Public invOlvement: a RealisT evaluation - the RAPPORT study
2017	NIHR Health Technology Assessment programme	Researching outcomes from forensic services for people with intellectual or developmental disabilities: a systematic review, evidence synthesis and expert and patient/carer consultation
2016	Agency for Healthcare Research and Quality (AHRQ)	Resident safety practices in nursing home settings
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Residents' perspectives of mobile X-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study.
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Reslizumab for eosinophilic asthma
2017	National Institute for Health and Care Excellence (NICE)	Reslizumab for treating severe eosinophilic asthma. NICE technology appraisal guidance 479
2023	Institute for Clinical and Economic Review (ICER)	Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH)
2023	Institute for Clinical and Economic Review (ICER)	Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH)
2020	Agency for Healthcare Research and Quality (AHRQ)	Resource allocation and pandemic response: an evidence synthesis to inform decision making
1998	NIHR Health Technology Assessment programme	Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions
1999	Agency for Healthcare Research and Quality (AHRQ)	Resource utilization and costs of care for treatment of chronic headache
2008	HAYES, Inc.	RESPeRATE (InterCure Ltd.) device to lower blood pressure
2004	Adelaide Health Technology Assessment (AHTA)	RESPeRATE (TM): self guided breathing device for the treatment of hypertension in the home
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Respiratory precautions for protection from bioaerosols or infectious agents: a review of the clinical effectiveness and guidelines
2015	Health Quality Ontario (HQO)	Respiratory therapy services in home care for individuals with chronic obstructive pulmonary disease (COPD): a rapid review
2021	NIHR Health Services and Delivery Research programme	Respite care and short breaks for young adults aged 18–40 with complex health-care needs: mixed-methods systematic review and conceptual framework development
2018	Belgian Health Care Knowledge Centre (KCE)	Responsible use of high-risk medical devices: the example of 3D printed medical devices
2014	NIHR Health Services and Delivery Research programme	Responsiveness of primary care services: development of a patient-report measure – qualitative study and initial quantitative pilot testing
2009	HAYES, Inc.	ResQPOD Impedance Threshold Device (ITD) (Advanced Circulatory Systems Inc.) for out-of-hospital cardiac arrest
2008	Adelaide Health Technology Assessment (AHTA)	ResQPOD impedance threshold device for cardiac arrest
2024	WorkSafeBC	Rest as treatment for adhesive capsulitis: 2024 update
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Restrictive red blood cell (RBC) transfusion thresholds: update
2014	Medical Services Advisory Committee (MSAC)	Resubmission Cetuximab and RAS testing under MBS 73330
2002	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Results of research about HTA: therapeutic procedures in oncology. IPE-02/32 (Public report)
2003	Agency for Healthcare Research and Quality (AHRQ)	Results of systematic review of research on diagnosis and treatment of coronary heart disease in women
2017	NIHR Public Health Research (PHR) programme	Results of the First Steps study: a randomised controlled trial and economic evaluation of the Group Family Nurse Partnership (gFNP) programme compared with usual care in improving outcomes for high-risk mothers and their children and preventing abuse
1998	University HealthSystem Consortium (UHC)	Results of the intravenous immunoglobulin surveillance study
2005	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Results of the study of the indications and adaptation of computerised tomography (CT) explorations and magnetic resonance (MR) in primary care in Catalonia
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2020	Malaysian Health Technology Assessment (MaHTAS)	Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2020	Agency for Healthcare Research and Quality (AHRQ)	Retention strategies for medications for addiction treatment in adults with opioid use disorder
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retesting patients with sleep apnea: guidelines and recommendations
2014	NIHR Health Services and Delivery Research programme	Rethinking resistance to 'big IT': a sociological study of why and when healthcare staff do not use nationally mandated information and communication technologies
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Retigabine for partial onset epilepsy - refractory
2011	NIHR Health Technology Assessment programme	Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation
2010	Adelaide Health Technology Assessment (AHTA)	Retinal implants to restore light perception in individuals blinded by retinitis pigmentosa
2002	Blue Cross Blue Shield Association (BCBS)	Retinal nerve fiber analysis for the diagnosis and management of glaucoma
2003	Blue Cross Blue Shield Association (BCBS)	Retinal nerve fiber layer analysis for the diagnosis and management of glaucoma
2014	Adelaide Health Technology Assessment (AHTA)	Retinal photography with a non-mydriatic retinal camera in people with diabetes
2016	Agency for Healthcare Research and Quality (AHRQ)	Retinal prostheses in the Medicare population
2016	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2017	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment update
2016	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC recommendation
2017	Health Quality Ontario (HQO)	Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC Recommendation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2000	Alberta Heritage Foundation for Medical Research (AHFMR)	Retinal tissue transplant
1998	Health Council of the Netherlands Gezondheidsraad (GR)	Retinitis pigmentosa. Assessment of a therapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retreatment, switching and extended therapy with boceprevir and telaprevir for chronic hepatitis C infection: a review of the clinical effectiveness and safety
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2005	National Institute for Health and Care Excellence (NICE)	Retrobulbar irradiation for thyroid eye disease. NICE interventional procedures guidance 148
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Retrograde endovascular balloon occlusion of the aorta (REBOA)
2006	National Institute for Health and Care Excellence (NICE)	Retrograde urethral sphincterometry. NICE interventional procedures guidance 167
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Retroluminal transobturatoric reposition sling for the treatment of stress urinary incontinence in men. Systematic Review
1994	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Reuse of disposable medical devices - conference
1991	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Reuse of single-use cardiac catheters
1998	Alberta Heritage Foundation for Medical Research (AHFMR)	Reuse of single-use devices: electrophysiology catheters
2022	NIHR Health Technology Assessment programme	REVascularisation of Ischaemic VEntricular Dysfunction (REVIVED): a randomised comparison of percutaneous coronary intervention (with optimal medical therapy) vs. optimal medical therapy alone for heart failure secondary to coronary disease
2023	Swiss Federal Office of Public Health (FOPH)	Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS)
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS). [Protocol]
2014	Belgian Health Care Knowledge Centre (KCE)	Revascularization for lower limb peripheral arterial disease
1996	Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS)	Revascularization procedures for the treatment of stable angina pectoris: a state of the art review - nonsystematic review
2004	NIHR Horizon Scanning Centre (NIHR HSC)	Reveal Plus (TM) implantable loop recorders for the investigation of syncope and other events - horizon scanning review
2008	HAYES, Inc.	Reverse shoulder total joint prosthesis
2014	HAYES, Inc.	Reverse shoulder total joint prosthesis
2007	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Review of arthroplasties registers: international experiences
1998	Australian Health Technology Advisory Committee (AHTAC)	Review of automated and semi-automated cervical screening devices
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for acute lymphoblastic leukaemia
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for chronic lymphocytic leukaemia
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for previously treated advanced gastric cancer
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for previously treated advanced hepatocellular carcinoma
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for previously treated multiple myeloma
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for prostate cancer
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for treating advanced urothelial carcinoma
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for treating early or advanced HER2-positive breast cancer
2006	Medical Services Advisory Committee (MSAC)	Review of current practices and future directions in the diagnosis, prevention and treatment of lymphoedema in Australia: report to the Australian Health Ministers' Advisory Council February 2004
2022	Adelaide Health Technology Assessment (AHTA)	Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia
2020	Health Information and Quality Authority (HIQA)	Review of guidance for the operation of emergency medical dispatch centres in the context of COVID-19 and beyond
2004	NIHR Health Technology Assessment programme	Review of guidelines for good practice in decision-analytic modelling in health technology assessment
2005	Alberta Heritage Foundation for Medical Research (AHFMR)	Review of Health Technology Assessment products 2003 - 2004
2003	Alberta Heritage Foundation for Medical Research (AHFMR)	Review of health technology assessment skills development program
2019	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Review of immunoglobulin use for chronic inflammatory demyelinating polyneuropathy
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Review of immunoglobulin use for primary immunodeficiency diseases with antibody deficiency
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Review of immunoglobulin use for primary immunodeficiency diseases with antibody deficiency
2011	Medical Services Advisory Committee (MSAC)	Review of interim funded service: Artificial intervertebral disc replacement - lumbar
2014	Medical Services Advisory Committee (MSAC)	Review of interim funded service: breast Magnetic Resonance Imaging (MRI)
2011	Medical Services Advisory Committee (MSAC)	Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011	Adelaide Health Technology Assessment (AHTA)	Review of interim funded service: vertebroplasty and new review of kyphoplasty